Literature DB >> 20168308

Removal of melatonin receptor type 1 induces insulin resistance in the mouse.

Susana Contreras-Alcantara1, Kenkichi Baba, Gianluca Tosini.   

Abstract

The incidence of obesity, insulin resistance, and type 2 diabetes (T2D) is increasing at an alarming rate worldwide. Emerging experimental evidence suggests that the hormone melatonin plays an important role in the regulation of glucose metabolisms. In this study, we report that removal of melatonin receptor type 1 (MT1) significantly impairs the ability of mice to metabolize glucose and such inability is probably due to an increased insulin resistance in these mice. Our data suggest that MT1 receptors are implicated in the pathogenesis of T2D and open the door for a detailed exploration on the mechanisms by which MT1 receptors signaling may affect glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20168308      PMCID: PMC2929321          DOI: 10.1038/oby.2010.24

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  11 in total

Review 1.  Functional MT1 and MT2 melatonin receptors in mammals.

Authors:  Margarita L Dubocovich; Magdalena Markowska
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

2.  Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.

Authors:  H Duplain; R Burcelin; C Sartori; S Cook; M Egli; M Lepori; P Vollenweider; T Pedrazzini; P Nicod; B Thorens; U Scherrer
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

3.  Partial gene deletion of endothelial nitric oxide synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension.

Authors:  Stéphane Cook; Olivier Hugli; Marc Egli; Barbara Ménard; Sébastien Thalmann; Claudio Sartori; Christophe Perrin; Pascal Nicod; Bernard Thorens; Peter Vollenweider; Urs Scherrer; Rémy Burcelin
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

4.  Melatonin modulates visual function and cell viability in the mouse retina via the MT1 melatonin receptor.

Authors:  Kenkichi Baba; Nikita Pozdeyev; Francesca Mazzoni; Susana Contreras-Alcantara; Cuimei Liu; Manami Kasamatsu; Theresa Martinez-Merlos; Enrica Strettoi; P Michael Iuvone; Gianluca Tosini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

5.  Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes.

Authors:  Cendrine Cabou; Patrice D Cani; Gérard Campistron; Claude Knauf; Caroline Mathieu; Claudio Sartori; Jacques Amar; Urs Scherrer; Rémy Burcelin
Journal:  Diabetes       Date:  2007-09-05       Impact factor: 9.461

Review 6.  Melatonin, endocrine pancreas and diabetes.

Authors:  Elmar Peschke
Journal:  J Pineal Res       Date:  2008-01       Impact factor: 13.007

7.  Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose.

Authors:  Eckhard Mühlbauer; Elena Gross; Karin Labucay; Sabine Wolgast; Elmar Peschke
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

8.  Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice.

Authors:  Claudio Sartori; Pierre Dessen; Caroline Mathieu; Anita Monney; Jonathan Bloch; Pascal Nicod; Urs Scherrer; Hervé Duplain
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.

Authors:  Valeriya Lyssenko; Cecilia L F Nagorny; Michael R Erdos; Nils Wierup; Anna Jonsson; Peter Spégel; Marco Bugliani; Richa Saxena; Malin Fex; Nicolo Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Peter Nilsson; Johanna Kuusisto; Jaakko Tuomilehto; Michael Boehnke; David Altshuler; Frank Sundler; Johan G Eriksson; Anne U Jackson; Markku Laakso; Piero Marchetti; Richard M Watanabe; Hindrik Mulder; Leif Groop
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

10.  A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Authors:  Nabila Bouatia-Naji; Amélie Bonnefond; Christine Cavalcanti-Proença; Thomas Sparsø; Johan Holmkvist; Marion Marchand; Jérôme Delplanque; Stéphane Lobbens; Ghislain Rocheleau; Emmanuelle Durand; Franck De Graeve; Jean-Claude Chèvre; Knut Borch-Johnsen; Anna-Liisa Hartikainen; Aimo Ruokonen; Jean Tichet; Michel Marre; Jacques Weill; Barbara Heude; Maithé Tauber; Katleen Lemaire; Frans Schuit; Paul Elliott; Torben Jørgensen; Guillaume Charpentier; Samy Hadjadj; Stéphane Cauchi; Martine Vaxillaire; Robert Sladek; Sophie Visvikis-Siest; Beverley Balkau; Claire Lévy-Marchal; François Pattou; David Meyre; Alexandra I F Blakemore; Marjo-Riita Jarvelin; Andrew J Walley; Torben Hansen; Christian Dina; Oluf Pedersen; Philippe Froguel
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

View more
  33 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 2.  Nutritional supplements and their effect on glucose control.

Authors:  Tanya Lee; Jean-Jacques Dugoua
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

Review 3.  Chronic sleep deprivation and seasonality: implications for the obesity epidemic.

Authors:  G Cizza; M Requena; G Galli; L de Jonge
Journal:  J Endocrinol Invest       Date:  2011-06-27       Impact factor: 4.256

Review 4.  Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.

Authors:  Gianluca Tosini; Sharon Owino; Jean-Luc Guillaume; Ralf Jockers
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

Review 5.  Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review.

Authors:  Mohsen Imenshahidi; Golamreza Karimi; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-01-30       Impact factor: 3.000

Review 6.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

7.  Pgc-1α and Nr4a1 Are Target Genes of Circadian Melatonin and Dopamine Release in Murine Retina.

Authors:  Stefanie Kunst; Tanja Wolloscheck; Debra K Kelleher; Uwe Wolfrum; S Anna Sargsyan; P Michael Iuvone; Kenkichi Baba; Gianluca Tosini; Rainer Spessert
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

8.  Distribution of MT1 melatonin receptor promoter-driven RFP expression in the brains of BAC C3H/HeN transgenic mice.

Authors:  E B Adamah-Biassi; Y Zhang; H Jung; S Vissapragada; R J Miller; M l Dubocovich
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

Review 9.  Melatonin transport into mitochondria.

Authors:  Juan C Mayo; Rosa M Sainz; Pedro González-Menéndez; David Hevia; Rafael Cernuda-Cernuda
Journal:  Cell Mol Life Sci       Date:  2017-08-21       Impact factor: 9.261

10.  Role of melatonin on diabetes-related metabolic disorders.

Authors:  Javier Espino; José A Pariente; Ana B Rodríguez
Journal:  World J Diabetes       Date:  2011-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.